HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Inhibition of pathologic retinal neovascularization by alpha-defensins.

Abstract
Proliferative retinopathies, such as those complicating prematurity and diabetes, are major causes of blindness. A prominent feature of these retinopathies is excessive neovascularization, which is orchestrated by the hypoxia-induced vascular endothelial growth factor (VEGF) stimulating endothelial cells and the integrin-mediated adhesive interactions of endothelial cells with extracellular matrix components such as fibronectin (FN). Recently, we demonstrated that alpha-defensins interfere with alpha5beta1-FN interactions and dependent endothelial cell functions. Here, alpha-defensins were studied in hypoxia-induced proliferative retinopathy. In vitro, alpha-defensins specifically inhibited alpha5beta1-integrin-dependent migration of bovine retinal endothelial cells (BRECs) to FN, attenuated the VEGF-stimulated increase in endothelial permeability, and blocked BREC proliferation and capillary sprout formation in 3-dimensional fibrin-matrices. An up-regulation of beta1-integrin and FN was observed in the retinal vessels in the mouse model of hypoxia-induced retinal angiogenesis. Systemic and local administration of alpha-defensins reduced retinal neovascularization by 45% and 60%, respectively, and this effect was comparable to the inhibitory effect of alpha5beta1-blocking antibody. alpha-Defensins were detected in human diabetic retinas associated with normal retinal vessels but were absent from proliferative lesions. Together, these data show that alpha-defensins inhibit pathologic retinal neovascularization in vivo and may provide a clinically efficient strategy against proliferative retinopathies.
AuthorsMatina Economopoulou, Khalil Bdeir, Douglas B Cines, Franz Fogt, Yasmina Bdeir, Jacek Lubkowski, Wuyuan Lu, Klaus T Preissner, Hans-Peter Hammes, Triantafyllos Chavakis
JournalBlood (Blood) Vol. 106 Issue 12 Pg. 3831-8 (Dec 01 2005) ISSN: 0006-4971 [Print] United States
PMID16123222 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • alpha-Defensins
Topics
  • Animals
  • Apoptosis (drug effects, physiology)
  • Cell Adhesion (drug effects, physiology)
  • Cell Movement (drug effects, physiology)
  • Cell Proliferation (drug effects)
  • Cells, Cultured
  • Disease Models, Animal
  • Endothelial Cells (drug effects, metabolism)
  • Humans
  • Hypoxia (physiopathology)
  • Immunohistochemistry
  • In Situ Nick-End Labeling
  • Mice
  • Retina (metabolism, pathology, physiopathology)
  • Retinal Diseases (metabolism, physiopathology)
  • Retinal Neovascularization (metabolism, physiopathology)
  • Retinal Vessels (metabolism)
  • alpha-Defensins (metabolism, pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: